ARCHIVES

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

Fox Chase Cancer Center plans $1 billion expansion that would double its size.

October 22, 2004

FDA Employee Inspired to Compose an Anthem for the Agency.

August 4, 2006

ACS Plans To Review Prostate Cancer Screening Guideline

March 20, 2009

Cancer Letter Founder Receives ACCC Award, Stresses Importance Of Bypass Budget

March 20, 1992

About Need For Cancer Research Funding

February 3, 1995

In Brief: Upton Not Planning To Leave NCI, As Hinted By Califano, Over New Ethics Regulations

March 30, 1979